09:49 AM EST - Oncolytics Biotech® Inc : Announced financial results for the quarter ended September 30, 2018. At which date, the company reported $16.2 million in cash and cash equivalents. The net loss for the third quarter of 2018 was $3.3 million or $0.20 per share compared to a net loss of $3.0 million or $0.20 per share for the period one year ago, on a consolidated basis. Oncolytics Biotech® Inc
shares T.ONC are trading up $0.03 at $0.85.
